Rapajić-Moran Ivana, Filipić Brankica, Rajković Dragana, Rakić Milan, Stojiljković Dragana, Letić Bojana, Urošević Jasna, Bogavac-Stanojević Nataša
Department of Social Pharmacy and Pharmaceutical Legislation, Doctoral Studies, University of Belgrade-Faculty of Pharmacy, Belgrade, Serbia.
Department of Microbiology and Immunology, University of Belgrade-Faculty of Pharmacy, Belgrade, Serbia.
PLoS One. 2025 Apr 29;20(4):e0322584. doi: 10.1371/journal.pone.0322584. eCollection 2025.
Cervical cancer is a significant public health concern in Serbia, with high morbidity and mortality rates (27 and 14.2 per 100,000 women, respectively in 2020). The primary cause of cervical cancer is human papillomavirus (HPV) infection, and HPV vaccination has proven to be an effective prevention strategy. This publication discusses the implementation of the first pharmacy-based education (PBE) program realized through the project of Pharmaceutical Chamber of Serbia - "Ask me about HPV" which aimed at raising awareness of the general population about the importance of HPV vaccination. The program aimed to strengthen the role of community pharmacists in the HPV vaccination roll-out. A total of 250 pharmacists were selected and trained to provide information on HPV infection and promote vaccination uptake. The program aimed to counsel and to educate young adults and parents/guardians. A total of 24,327 subjects were educated during the program's implementation from February to May 2023, young adults (N=11,313) and parents/guardians (N=13,014). Data showed that only 4.9% of young adults and 6.4% of children (of the parents/guardians surveyed) in Serbia are vaccinated against HPV. The questionaries of 1,387 subjects already vaccinated were excluded from the further analysis and final analysis was performed based on the counseling of 22,941 participants. A significantly higher percentage of parents/guardians stated that they would have their children vaccinated against HPV after counseling at the pharmacy than young adults (42.3% and 34.1% respectively). On the other hand, of those respondents who stated they would get vaccinated after consulting at the pharmacy, a significantly higher number of young adults (51%), compared to parents/guardians (48%), would receive the vaccine specifically at the pharmacy. The results of the project indicate that education of the general population on the benefits of HPV vaccination is highly needed. The expected outcomes of this educational program are increased awareness of the burden of illness, improved consumer education, the potential for higher vaccination rates, and consequently a reduction in cervical cancer incidence and mortality in Serbia.
宫颈癌是塞尔维亚一个重大的公共卫生问题,发病率和死亡率都很高(2020年分别为每10万名女性中有27例和14.2例)。宫颈癌的主要病因是人类乳头瘤病毒(HPV)感染,而HPV疫苗接种已被证明是一种有效的预防策略。本出版物讨论了通过塞尔维亚药学会的项目——“问我关于HPV”实施的首个基于药房的教育(PBE)计划,该计划旨在提高普通民众对HPV疫苗接种重要性的认识。该计划旨在加强社区药剂师在HPV疫苗接种推广中的作用。总共挑选并培训了250名药剂师,以提供有关HPV感染的信息并促进疫苗接种。该计划旨在为年轻人和父母/监护人提供咨询和教育。在2023年2月至5月计划实施期间,共有24327名受试者接受了教育,其中年轻人(N = 11313)和父母/监护人(N = 13014)。数据显示,塞尔维亚只有4.9%的年轻人和6.4%的儿童(在接受调查的父母/监护人中)接种了HPV疫苗。对1387名已接种疫苗的受试者的问卷进行了排除,进一步分析和最终分析是基于对22941名参与者的咨询进行的。与年轻人相比,有更高比例的父母/监护人表示在药房咨询后会让他们的孩子接种HPV疫苗(分别为42.3%和34.1%)。另一方面,在那些表示在药房咨询后会接种疫苗的受访者中,与父母/监护人(48%)相比,有更高比例的年轻人(51%)会在药房专门接种疫苗。该项目的结果表明,非常需要对普通民众进行HPV疫苗接种益处的教育。这个教育计划的预期成果是提高对疾病负担的认识、改善消费者教育、提高疫苗接种率的潜力,从而降低塞尔维亚宫颈癌的发病率和死亡率。